TWD 16.15
(-9.01%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 119.91 Million TWD | 22.21% |
2022 | 167.66 Million TWD | 20.49% |
2021 | 139.15 Million TWD | -3.6% |
2020 | 144.35 Million TWD | 2.09% |
2019 | 141.4 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 61.28 Million TWD | -19.14% |
2024 Q2 | 58.55 Million TWD | -4.44% |
2023 Q1 | 66.78 Million TWD | 119.27% |
2023 Q4 | 75.79 Million TWD | 0.0% |
2023 FY | 204.9 Million TWD | 22.21% |
2023 Q2 | 66.78 Million TWD | 0.0% |
2023 Q3 | 75.79 Million TWD | 13.48% |
2022 Q3 | 30.46 Million TWD | 0.0% |
2022 FY | 167.66 Million TWD | 20.49% |
2022 Q4 | 30.46 Million TWD | 0.0% |
2021 FY | 139.15 Million TWD | -3.6% |
2020 FY | 144.35 Million TWD | 2.09% |
2019 FY | 141.4 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -36346.809% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 6.078% |
Level Biotechnology Inc. | 151.99 Million TWD | 21.108% |
Sagittarius Life Science Corp | 135.85 Million TWD | 11.735% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | -58.07% |
TaiMed Biologics Inc. | 225.23 Million TWD | 46.762% |
GlycoNex Incorporation | 995 Thousand TWD | -11951.256% |
VBI | 32.55 Million TWD | -268.331% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 53.319% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 38.25% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -160.544% |
Visgeneer Inc. | 67.48 Million TWD | -77.692% |
Mycenax Biotech Inc. | -375.19 Million TWD | 131.96% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 76.493% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -87.644% |
Neith Corporation | 66.87 Million TWD | -79.31% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 91.696% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -308.524% |
Enimmune corporation | 220.1 Million TWD | 45.521% |
TaiRx, Inc. | 217.13 Million TWD | 44.776% |
CHO Pharma, Inc. | 268.99 Million TWD | 55.423% |
EirGenix Inc. | 236.74 Million TWD | 49.35% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -14.91% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 66.47% |
Lin BioScience, Inc. | 1.09 Billion TWD | 89.068% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 54.948% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -142.384% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -10972.022% |
Lukas Biomedical Inc. | 177.45 Million TWD | 32.426% |
RBC Bioscience Corporation | 58.35 Million TWD | -105.48% |
BiOptic Inc. | 108.69 Million TWD | -10.321% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -133133.333% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -72.906% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -4485.468% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 81.378% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -28.471% |
NaviFUS Corp. | 11.82 Million TWD | -913.867% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 37.131% |
Sinew Pharma Inc. | 186.25 Million TWD | 35.62% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -61.99% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 45.594% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -189.072% |
AP Biosciences Inc | 32.25 Million TWD | -271.779% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 93.52% |
3D Global Biotech Inc. | 5.27 Million TWD | -2173.606% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 62.212% |
Intech Biopharm Corporation | -163.99 Million TWD | 173.118% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 89.381% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -189.065% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 29.28% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 18.441% |
TCI GENE Inc. | 174.61 Million TWD | 31.33% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -666066.667% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 60.155% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 58.788% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -42.844% |
PharmaEngine, Inc. | 441.78 Million TWD | 72.858% |
Savior Lifetec Corporation | 223.36 Million TWD | 46.318% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 53.663% |
OBI Pharma, Inc. | 2.01 Billion TWD | 94.053% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 13.653% |
Acepodia, Inc. | 452.56 Million TWD | 73.504% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 77.833% |